STOCK TITAN
  1. Home
  2. Sec-filings
  3. APLT
  4. [SCHEDULE 13G/A] Applied Therapeutics, Inc. SEC Filing

[SCHEDULE 13G/A] Applied Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock APLT logo
Applied Therapeutics

NASDAQ:APLT

APLT Rankings

#7375 Ranked by Market Cap
N/A Ranked by Dividends

APLT Latest News

Jun 17, 2025
Applied Therapeutics Announces Key Leadership Appointments
May 18, 2025
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 13, 2025
Applied Therapeutics Reports First Quarter 2025 Financial Results
May 9, 2025
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Apr 14, 2025
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

APLT Latest SEC Filings

Jul 3, 2025
[Form 4] Applied Therapeutics, Inc. Insider Trading Activity

APLT Stock Data

55.92M
132.64M
5.68%
107.37%
16.78%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK